Streetbeat News

XRTX

XORTX Therapeutics Inc.

https://www.xortx.com

Industry

Biotechnology

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Several stocks are experiencing significant pre-market trading movements. AERWINS Technologies Inc. (AWIN), Ascent Solar Technologies, Inc. (ASTI), WiSA Technologies, Inc. (WISA), Lytus Technologies Holdings PTV. Ltd. (LYT), LM Funding America, Inc. (LMFA), Soluna Holdings, Inc. (SLNH), Organovo Holdings, Inc. (ONVO), Argo Blockchain plc (ARBK), CleanSpark, Inc. (CLSK), and Logitech International S.A. (LOGI) are among the gainers. LumiraDx Limited (LMDX), Markforged Holding Corporation (MKFG), XORTX Therapeutics Inc. (XRTX), TC Biopharm (Holdings) Plc (TCBP), IonQ, Inc. (IONQ), The Alkaline Water Company Inc. (WTER), SeaStar Medical Holding Corporation (ICU), Alaunos Therapeutics, Inc. (TCRT), Harpoon Therapeutics, Inc. (HARP), and INVO Bioscience, Inc. (INVO) are among the losers.

Portfolio Pulse from Lisa Levin

October 24, 2023 | 11:31 am

US stocks traded lower with the Dow Jones index falling over 100 points. The Chicago Fed National Activity Index increased to +0.02 in September from -0.22 in the prior month. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw their shares rise after various strategic collaborations and agreements. Li-Cycle Holdings Corp., Revolution Medicines, and XORTX Therapeutics saw their shares drop due to halted projects and clinical trial data.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 1:43 pm

The article lists the top gainers and losers in pre-market trading. LumiraDx Limited's shares surged after a strategic collaboration with AstraZeneca and Everton. Akumin Inc. rose after an agreement with Stonepeak to go private. Textainer Group Holdings Limited gained after agreeing to be acquired by Stonepeak. Harpoon Therapeutics, Inc. climbed after disclosing updated interim data from a clinical trial. Roivant Sciences Ltd. rose after Roche agreed to acquire Telavant. Troika Media Group, Inc. fell after reporting financial results. XORTX Therapeutics Inc. dipped after a significant jump on Friday.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 11:32 am

The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers were XORTX Therapeutics, Lipella Pharmaceuticals, and Catalyst Biosciences, while the losers included WEBUY GLOBAL, SolarEdge Technologies, and Processa Pharmaceuticals. Factors influencing these movements include FDA clearances, strategic appointments, acquisitions, and financial results.

Portfolio Pulse from Lisa Levin

October 20, 2023 | 5:45 pm

Shares of Xortx Therapeutics Inc. (NASDAQ:XRTX) are trading higher on unusually heavy trading volume, despite no company-specific news. Over 45 million shares have been traded in the session, compared to the stock's 100-day average of just over 200 thousand shares. The company's shares are up 52% at 53 cents at the time of publication.

Portfolio Pulse from Erica Kollmann

October 20, 2023 | 3:33 pm

US stocks traded lower with the Dow Jones index falling around 50 points. American Express Co reported better-than-expected earnings for Q3 with a YoY revenue growth of 12% to $15.38 billion. XORTX Therapeutics, Lipella Pharmaceuticals, and Urgent.ly saw significant stock increases, while SolarEdge Technologies, Adial Pharmaceuticals, and Webuy Global experienced notable drops. SolarEdge issued preliminary Q3 revenue results below estimates and lowered its non-GAAP gross margin guidance. Adial announced a $4 million private placement priced at-the-market under Nasdaq rules. Webuy Global priced a $15.2 million IPO of 3.8 million ordinary shares at $4 per share.

Portfolio Pulse from Lisa Levin

October 20, 2023 | 1:43 pm

Several stocks are experiencing significant pre-market trading movements. XORTX Therapeutics, Urgent.ly, Aravive, Wheeler Real Estate Investment Trust, Intelligent Living Application Group, SEALSQ Corp, American Well Corporation, Knight-Swift Transportation Holdings, Ucommune International, and Bowlero Corp are among the gainers. Cuentas, WEBUY GLOBAL, SolarEdge Technologies, Processa Pharmaceuticals, Asset Entities, SeaStar Medical Holding Corporation, Arcutis Biotherapeutics, Atreca, Spectral AI, and Intuitive Surgical are among the losers.

Portfolio Pulse from Lisa Levin

October 20, 2023 | 11:42 am

Several stocks are moving in pre-market trading. Maris-Tech Ltd. (MTEK) shares rose 38% after the launch of Jupiter Drones. ParaZero Technologies Ltd. (PRZO) shares gained 27.6% after receiving authorization for drones to operate over populated areas. Avidity Biosciences, Inc. (RNA) rose 9.1% after disclosing positive AOC 1001 data. Shift Technologies, Inc. (SFT) fell 85% as it intends to file a voluntary Chapter 11 petition. Kubient, Inc. (KBNT) shares fell 21.2% after implementing a 36% reduction in the company's workforce.

Portfolio Pulse from Lisa Levin

October 09, 2023 | 12:20 pm

The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers were Applied UV, Inc., ParaZero Technologies Ltd., and American Oncology Network, Inc. The losers included OMNIQ Corp., VivoPower International PLC, and CalAmp Corp. The article also mentions several other stocks that experienced significant price changes.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 5:59 pm

Pioneer Natural Resources Company's shares rose by 11.6% in pre-market trading due to reports of Exxon Mobil Corp. nearing a purchase deal with the company, potentially worth around $60 billion. Other notable pre-market movers include Vaccinex, Inc., RVL Pharmaceuticals plc, and ETAO International Co., Ltd. On the other hand, OMNIQ Corp., Near Intelligence, Inc., and AgriFORCE Growing Systems Ltd. saw significant drops in their share prices.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 12:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.